INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,330,235 | +9.3% | 52,693 | -8.7% | 0.32% | +21.1% |
| Q2 2023 | $1,217,399 | +17.0% | 57,724 | -5.6% | 0.26% | +13.5% |
| Q1 2023 | $1,040,603 | -19.3% | 61,140 | -5.3% | 0.23% | -20.7% |
| Q4 2022 | $1,289,969 | +24.0% | 64,563 | +33.8% | 0.29% | +20.8% |
| Q3 2022 | $1,040,000 | -44.4% | 48,246 | -49.1% | 0.24% | -38.9% |
| Q2 2022 | $1,869,000 | -22.7% | 94,730 | -7.9% | 0.39% | +8.6% |
| Q1 2022 | $2,418,000 | -14.5% | 102,858 | -0.9% | 0.36% | -1.9% |
| Q4 2021 | $2,829,000 | – | 103,776 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |